Liver Diseases: all 2,094 studies

Page 6 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.

• Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic SteatohepatitisCompletedNCT03061721Phase 2Results posted
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic SteatohepatitisTerminatedNCT03059446Phase 2Results posted
• Anti-LPS Antibody Treatment for Pediatric NAFLDCompletedNCT03042767Phase 2Results posted
• Palliative Care for Non-Malignant Diseases (COMPASS Trial)TerminatedNCT03022630Not applicableResults posted
• A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in CanadaCompletedNCT02985450Results posted
• Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC DiagnosisCompletedNCT02973516Phase 2Results posted
• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.CompletedNCT02970942Phase 2Results posted
• 19 Versus 22-Gauge Needle for EUS-LBCompletedNCT02967991Not applicableResults posted
• Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLDCompletedNCT02941549Phase 2Results posted
• deLIVER: Direct Acting Antiviral Effects on the LiverCompletedNCT02938013Phase 4Results posted
• Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02875392Not applicableResults posted
• A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic FunctionCompletedNCT02871570Phase 1Results posted
• Controlled Attenuation Parameter (CAP) in Liver AllograftsCompletedNCT02798861Results posted
• A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASHCompletedNCT02784444Phase 2Results posted
• Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)CompletedNCT02781584Phase 2Results posted
• A Physical Activity Program in End-state Liver DiseaseCompletedNCT02776553Not applicableResults posted
• Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in AdolescentsCompletedNCT02726542Early Phase 1Results posted
• Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) StudyTerminatedNCT02717949Phase 4Results posted
• Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and LipodystrophyCompletedNCT02684591Phase 2Results posted
• Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy SubjectsCompletedNCT02683577Phase 1Results posted
• Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD SubjectsCompletedNCT02681055Phase 2Results posted
• Determination of Liver Stiffness in Chronic Liver Disease Patients by Acoustic Radiation Force Imaging (ARFI) UltrasoundCompletedNCT02652221Not applicableResults posted
• Effect of Hepatic Impairment on the Pharmacokinetics of AlectinibCompletedNCT02621047Phase 1Results posted
• Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)TerminatedNCT02613403Phase 2Results posted
• Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT02605616Phase 2Results posted
• The Patient-Reported Outcomes Project of HCV-TARGETCompletedNCT02601820Results posted
• The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver DiseaseCompletedNCT02546609Phase 2Results posted
• The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/SteatohepatitisCompletedNCT02528305Not applicableResults posted
• Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)CompletedNCT02523196Phase 3Results posted
• Dietary Treatment Study of Pediatric NAFLDCompletedNCT02513121Not applicableResults posted
• Noninvasive Subharmonic Aided Pressure Estimation of Portal HypertensionCompletedNCT02489045Phase 4Results posted
• Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure StudyCompletedNCT02457637Results posted
• Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological StudiesTerminatedNCT02447926Not applicableResults posted
• Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive ProceduresCompletedNCT02389621Phase 3Results posted
• Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02369536Not applicableResults posted
• Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentCompletedNCT02367872Phase 1Results posted
• Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver DiseaseCompletedNCT02366845Phase 4Results posted
• A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.CompletedNCT02354976Phase 2Results posted
• ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLDCompletedNCT02330549Phase 2Results posted
• A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHCompletedNCT02279524Phase 2Results posted
• A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic PatientsCompletedNCT02279407Phase 2Results posted
• An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver DiseaseCompletedNCT02262728Phase 2Results posted
• Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLDTerminatedNCT02244944Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and ThrombocytopeniaCompletedNCT02227693Phase 2Results posted
• Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT02217345Phase 2Results posted
• Magnetic Resonance Elastography in InfantsTerminatedNCT02201472Not applicableResults posted
• Usefulness of BiClamp Forceps for Liver Resection: A Randomized Clinical TrialCompletedNCT02197481Phase 3Results posted
• Tesamorelin Effects on Liver Fat and Histology in HIVCompletedNCT02196831Not applicableResults posted
• Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic ImpairmentCompletedNCT02170220Phase 1Results posted
• The Role of Obstructive Sleep Apnea in Children With Fatty Liver DiseaseTerminatedNCT02134522Not applicableResults posted
• PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy VolunteersCompletedNCT02121860Phase 1Results posted
• An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille SyndromeCompletedNCT02117713Phase 2Results posted
• Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)CompletedNCT02115347Phase 1Results posted
• Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an OptionCompletedNCT02094443Phase 2Results posted
• Ultrasound Method to Measure Fibrosis of the Liver in ChildrenTerminatedNCT02086708Not applicableResults posted
• Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic DecompensationCompletedNCT02084160Results posted
• A Study of IDN-6556 in Subjects With NAFLD and Raised TransaminasesCompletedNCT02077374Phase 2Results posted
• A2ALL-Patients Safety System Improvements in Living Donor Liver TransplantationCompletedNCT02073435Results posted
• To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy SubjectsCompletedNCT02063230Phase 1Results posted
• Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic CholestasisCompletedNCT02057718Phase 2Results posted
• Octaplas Pediatric Plasma Replacement TrialCompletedNCT02050841Phase 4Results posted
• An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS)CompletedNCT02047318Phase 2Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver TransplantCompletedNCT02010255Phase 2Results posted
• Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective ProcedureCompletedNCT01976104Phase 3Results posted
• Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsCompletedNCT01975935Phase 2Results posted
• Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective ProcedureCompletedNCT01972529Phase 3Results posted
• Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver DiseaseCompletedNCT01963845Phase 2Results posted
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic ImpairmentCompletedNCT01949545Phase 1Results posted
• The Association With Peptic Ulcer Disease and Hepatic Vein Pressure GradientCompletedNCT01944878Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver TransplantCompletedNCT01938430Phase 2Results posted
• Improving Communication About Serious IllnessCompletedNCT01933789Not applicableResults posted
• Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver DiseaseTerminatedNCT01930123Phase 2Results posted
• Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver DysfunctionCompletedNCT01912222Phase 1Results posted
• Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille SyndromeCompletedNCT01903460Phase 2Results posted
• A Pharmacokinetic Study of Baricitinib in Participants With Liver DiseaseCompletedNCT01870388Phase 1Results posted
• Amlexanox for Type 2 Diabetes and ObesityTerminatedNCT01842282Phase 2Results posted
• Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD PatientsCompletedNCT01811472Phase 2Results posted
• How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?CompletedNCT01790984Not applicableResults posted
• An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy VolunteersCompletedNCT01767103Phase 4Results posted
• Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control GroupCompletedNCT01754714Phase 3Results posted
• Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
• Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver FunctionCompletedNCT01732263Phase 1Results posted
• Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver DiseaseCompletedNCT01712711Phase 2Results posted
• Investigation of Synbiotic Treatment in NAFLDCompletedNCT01680640Not applicableResults posted
• Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With LipodystrophyCompletedNCT01679197Phase 2Results posted
• Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 2Results posted
• Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic SteatohepatitisCompletedNCT01654549Phase 2Results posted
• The Effect of Protein-enriched Diet on Body Composition and AppetiteCompletedNCT01634048Not applicableResults posted
• Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)CompletedNCT01600105Phase 4Results posted
• Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal CirculationCompletedNCT01579162Not applicableResults posted
• Pharmacokinetics of BAF312 in Patients With Hepatic ImpairmentCompletedNCT01565902Phase 1Results posted
• Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in ChildrenCompletedNCT01529268Phase 2/3Results posted
• Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver DiseaseCompletedNCT01501162Phase 4Results posted
• The Sleep, Liver Evaluation and Effective Pressure StudyCompletedNCT01482065Phase 2Results posted
• A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)CompletedNCT01465412Phase 1Results posted
• Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRITerminatedNCT01433016Phase 2Results posted
• Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)CompletedNCT01431521Phase 1Results posted
• Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin DeficiencyTerminatedNCT01379469Phase 2Results posted
• Rifaximin in Fatty Liver DiseaseTerminatedNCT01355575Phase 4Results posted
• Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic SurgeryCompletedNCT01324349Not applicableResults posted

← Liver Diseases overview